HESKA CORP
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: HESKA CORP, 10-Q, EX-10.41, 2000-08-14
Next: TARRAGON REALTY INVESTORS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION FROM THE REGISTRANT'S
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AS OF AND FOR THE SIX
MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) INCLUDED IN THE COMPANY'S REPORT
ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           5,650
<SECURITIES>                                     7,232
<RECEIVABLES>                                   11,419
<ALLOWANCES>                                     (264)
<INVENTORY>                                     11,853
<CURRENT-ASSETS>                                36,476
<PP&E>                                          26,633
<DEPRECIATION>                                (11,761)
<TOTAL-ASSETS>                                  54,011
<CURRENT-LIABILITIES>                           14,670
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       199,397
<OTHER-SE>                                   (164,878)
<TOTAL-LIABILITY-AND-EQUITY>                    54,011
<SALES>                                         26,137
<TOTAL-REVENUES>                                28,606
<CGS>                                           17,886
<TOTAL-COSTS>                                   17,886
<OTHER-EXPENSES>                                22,041
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (215)
<INCOME-PRETAX>                               (11,632)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (11,632)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (11,632)
<EPS-BASIC>                                     (0.35)
<EPS-DILUTED>                                   (0.35)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission